MSWA
TEVA icon

Marshall & Sterling Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Marshall & Sterling Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,000
Closed -$44.1K – 661
2024
Q4 		$44.1K Buy
+2,000
New +$36.4K 0.03% 137

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Marshall & Sterling Wealth Advisors's TEVA Position: Q1 2025 in Review

Marshall & Sterling Wealth Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2025, closing a stake of 2,000 shares — an estimated $44.1K sold.

Marshall & Sterling Wealth Advisors first reported a position in TEVA in Q4 2024 and held it in 1 quarter. The position peaked at $44.1K in Q4 2024. 563 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • Marshall & Sterling Wealth Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2025 after selling out during the quarter.
  • Marshall & Sterling Wealth Advisors sold 2,000 Teva Pharmaceutical Industries Limited shares in Q1 2025, an estimated $44.1K.
  • Marshall & Sterling Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2024 and held it in 1 quarter.
  • Marshall & Sterling Wealth Advisors's Teva Pharmaceutical Industries Limited position peaked at $44.1K in Q4 2024.
  • 563 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2025.

Based on Marshall & Sterling Wealth Advisors's 13F filing for Q1 2025, filed 15 May 2025.